Generic drug perspectives
Kaatz, B.
South Dakota Journal of Medicine 56(2): 61
2003
ISSN/ISBN: 0038-3317 PMID: 12621955 Document Number: 560999
Document emailed within 1 workday
Related Documents
Laroche, M-Laure.; Merle, L. 2005: Generic drug savings Annals of Internal Medicine 143(11): 844Brust, M.; Hawkins, C.F.; Grayson, D. 1990: Physicians' attitudes toward generic drug substitution by pharmacists Texas Medicine 86(3): 45-49
Niazi, A.; Lyons, J.B. 2002: Generic drug packaging leading to a critical incident Irish Medical Journal 95(10): 312
Gallagher, F. 2003: Generic drug packaging leading to a critical incident Irish Medical Journal 96(1): 31
Carrillo Norte, J.A.; Postigo Mota, S. 2012: Generic drugs: we must cut pharmaceutical spending but undertaking drug quality Revista de Enfermeria 35(2): 10-19
Cramer, R. 1985: Assistance from community pharmacists in identifying generic drug products American Journal of Hospital Pharmacy 42(9): 1936; 1938
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904
Meiners, C.; Sagaon-Teyssier, L.; Hasenclever, L.; Moatti, J.-P. 2011: Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? Plos one 6(8): E23478
Kaojarern, S.; Pattanaprateep, O. 2012: The effect of introducing inpatient mandatory generic drug substitution at Ramathobodi Hospital Journal of the Medical Association of Thailand 95(4): 519-525
Burkhart, C.G. 2004: And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange Journal of Drugs in Dermatology: Jdd 3(1): 11
Bergen-Cico, D 2013: Perspectives of U.S. Drug Policy: Observations and Advice From Drug Policy Administrators in Emerging Democracies in Central and Eastern Europe World Medical and Health Policy 5(4): 362-388
Navarro, R.P. 1998: Merging perspectives on drug value Managed Care Interface 11(1): 53-54
Apley, M.D. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Practical aspects of flexible labeling in feedlots Journal of the American Veterinary Medical Association 207(7): 901
Nowotny, O.H. 1978: Trends and perspectives in drug research and development Fortschritte der Medizin 96(12): 615
Kamada, T.; Sato, N.; Kawano, S. 1988: Perspectives in the drug therapy of peptic ulcer Nihon Rinsho. Japanese Journal of Clinical Medicine 46(1): 7-11
Zaigler, M.; Tantcheva-Poór, I.; Fuhr, U. 2000: Problems and perspectives of phenotyping for drug-metabolizing enzymes in man International Journal of Clinical Pharmacology and Therapeutics 38(1): 1-9
Grube, E.; Gerckens, U.; Buellesfeld, L. 2002: Drug-eluting stents: clinical experiences and perspectives Minerva Cardioangiologica 50(5): 469-473
Hainer, V. 2010: Drug treatment of obesity--current situation and perspectives Casopis Lekaru Ceskych 149(11): 513-519